Introduction
Natural products are the most feasible source of leading compounds in exploitation of anti-cancer drugs [1] . In recent years, chemists have shown great passion for seeking effective new chemical entities (NCE) from natural products and their derivatives.
Diosgenin (3β-hydroxy-5-spirostene, Di), is a conventional herbal sterols distilled from yams, fenugreek, and Costus speciosus [2] . Prominently, it is a characteristic initial intermediate for the synthesis of steroidal compositions, oral contraceptives and sex hormones. A series of preclinical and mechanistic investigations showed that Di contributed to multiple anti-cancer activities, such as restraining the hTERT gene expression in A549 lung cancer cells [3] , inhibiting breast cancer stem-like cells by the Wnt β-catenin signaling [4] , impeding hepatocellular carcinoma cells by increasing DDX3 expression [5] , and inducing prostate cancer cell apoptosis through activation of estrogen receptor-β [6] . Additionally, studies in recent decades demonstrated that Di has unique preventive/therapeutic outcomes not only against tumors, but also for other diseases such as diabetes [7] , myocardial infarction (AMI) [8] , acute liver injury [9] , goiter [10] , and alzheimer's disease (AD) [11] .
In consideration of the diverse biological activities of Di, researchers are interested in modifying the steroid structure of Di to obtain Di derivatives which had more efficient anti-cancer activities than that of Di. 1-Phenyl-(1H-1,2,3-triazol-4yl)-methoxy diosgenin, which is a simple phenyl R moiety attached via triazole to the parent molecule, showed almost three times decrease in IC50 value against A549 cells than that of Di [12] . Diosgenin-imidazolium salt derivatives were also synthesized and displayed significant cytotoxic activities against several human cancer cell lines 4 [13] . One of novel 22-oxo-26-selenocyanocholestanic steroids based on Di synthesized by Herrera et al. exhibited remarkable antiproliferative activity against Hela cells which is close to the clinical anticancer agent paclitaxel [14] . These successful examples demonstrated the promising steroidal structure of Di for discovery of new anticancer drugs.
Liposomes which were usually constituted of phospholipids and stabilized by cholesterol have been substantially investigated as drug carriers for targeting, modulating drug pharmacokinetics, and decreasing drug toxicity [15, 16] . Liposomes also can be used as solubilizing media to enhance solubility and bioavailability of insoluble drugs [17] . Di and our prepared analogues have an extremely similar sterol structure to cholesterol. It was reported that Di and the lipids formed highly stable complexes at the air/water interface [18] . Therefore, Di and its derivatives could be substituted for cholesterol to form novel stable liposome-like phytosomes. The prepared phytosomes were expected to enhance the solubility and bioavailability of the Di derivative for clinical transformation.
In this study, we first prepared several Di derivatives and screen the most potent candidate through the preliminary structure-activity relationship study. Then the liposome-like phytosomes were prepared by substituting Di and its derivative for cholesterol. The anti-cancer effects of free drugs and their phytosomes were investigated in non-small cell lung cancer cells.
Results and discussion

Synthesis and characterization of Di derivatives
Late stage functionalization (LSF), which uses the C-H bonds as points of potential variation, is a useful method to generate novel analogs of a lead structure without depending on de novo synthesis [19] . Recently, it is widely accepted that the aliphatic C-H oxidation could be an efficient approach to diversify complex structures at the sites remoting from the existing functionalities [20] . In the steroid structure of Di, there are abundant electrons in the double bond site for electrophilic addition. Based on this feature, we designed and synthesized a series of Di derivatives. The novel Di derivative FZU-0021-194-P2 (P2) which showed the most efficient effects of suppressing cell growth was screened (Figure 1) . The structure of P2 was further established by X-ray crystallographic analysis. CCDC1844665 contains the crystallographic data of P2. The data can be obtained free of charge from the Cambridge Crystallographic Data Center.
Anti-proliferative activity of P2
The anti-cancer effects of Di and its analogue P2 were tested in human lung cancer A549 and PC9 cell lines, human cervical cancer Hela cell line, and human hepatoma HepG2 cell line using MTT assays. All cells were treated with each compound at indicated concentrations for 48 h. It was found that Di and P2 could suppress two lung cancer cells more sensitively than Hela and HepG2 cells ( Table 1) . The IC50 values of P2 in A549 and PC9 cells were 11.8 and 15.2 μM, respectively, which were much lower than those of Di (55.0 and 85.8 μM, respectively). Figure 2A shows that Di and P2 could suppress the cell viability in a dosage dependent manner in A549 and PC9
cells. All the results demonstrated that P2 had much stronger antiproliferative activity against A549 and PC9 cells than that of Di.
Cell cycle arrest and apoptosis induced by P2
Cell cycle is the series of events that take place in cells for their propagation and multiplication. The phases consist of the Gap 1 phase (G1), Synthesis phase (S), Mitosis phase (M), and Gap 2 phase (G2). Di induced cell cycle arrest in different phases against different cancer cells. It was reported that Di could induce G2/M cell cycle arrest in liver cancer cells [21] , arrest SCC cells at the sub-G1 phase [22] , and impede cell cycle progression in the G0/G1 phase in A549 cells [23] . To determine the anti-proliferative mechanisms of Di and P2, the effects of Di and P2 on cell cycle distributions were examined in A549 and PC9 cells. As shown in Figure 2B , Di and P2 could induce A549 and PC9 cell cycle arrest in G0/G1 phase (at a concentration 20 μM for A549 cells and 30 μM for PC9 cells for 48 h). To our surprise, the cell proportion in G0/G1 phase induced by P2 at a low concentration (5 μM) was exceeding that of Di at high concentrations. These results demonstrated that P2 was more potent than Di to inhibit cell cycle progression.
Apoptosis, the programmed cell death, is a physiological process that is accurately regulated at genetic level resulting in the removal of damaged cells in a controlled manner [24] . Most of the chemotherapeutic drugs exert effects through the mechanism of apoptosis. It was reported that diosgenin could induce early apoptosis in human prostate DU145 cancer cells [25] and cause late apoptosis in human cervical HeLa cancer cells [26] . In order to explore the death mechanism of P2, A549 and PC9 cells were treated with P2 and Di for 48 h and the proportion of cells undergone apoptosis was counted through Annexin V-FITC/PI staining and followed by flow cytometry analysis. As shown in Figure 2C , each scatter plot is divided into four quadrants. The cells in Q1, Q2, Q3, and Q4 quadrants represent necrotic cells, late apoptotic cells, early apoptotic cells, and viable cells, respectively. The results showed that P2 significantly induced apoptosis in both A549 and PC9 cells compared with Di. In A549 cells, P2 at 20 μM induced 51.1% early apoptosis, while Di at the same concentration induced only 3.75% early apoptosis. P2 at 5 μM showed even stronger early apoptosis induction effects than that of Di at 20 μM. In PC9 cells, P2 at 30 μM induced 34.4% early and late apoptosis, while Di only induced 6.7% early and late apoptosis. The results clearly showed that P2 was more potent than Di in inducing apoptosis in A549 and PC9 cells.
Preparation and characterization of P2 phytosomes (P2P)
Formulating small-molecule drugs into nanometer-scaled particles have been widely investigated for targeted drug delivery to tumors. These nanoparticles can passively accumulate in tumors via enhanced permeability and retention (EPR) effect, thus decreasing the toxicity of non-selective bio-distribution [27] . Considering the advantages of liposomes as a drug delivery system for chemotherapeutic drugs and the similar sterol structures in cholesterol and Di, complexes of phospholipids and Di or P2 were prepared to further enhance the solubility and improve the pharmacokinetic profiles of Di and P2 for better clinical transformation.
Phytosomes are lipid compatible molecular complexes of phospholipids and natural active ingredients, in which the active ingredients containing sufficient polar functional groups such as COOH, OH, NH2 are anchored to the polar head of phospholipids by the polar and hydrogen-bond interactions [28] . Because of the interaction, phospholipids and natural active ingredients could undergo self-assembly into stable structures of vesicles in aqueous solution, which could act as a vehicle to facilitate membrane transport [29] . Compared to liposomes, phytosomes could load more drug molecules, and showed enhanced stability in the lyophilization and reconstitution processes prior to use [30] . Phytosomes have been used as drug delivery systems of several insoluble natural drugs in recent years. Sinigrin [31] and epigallocatechin-3-O-gallate [32] loaded in phytosomes showed stronger antiproliferative activities than free drugs against melanoma cells and breast cancer cells, respectively.
In this work, Di phytosomes (DiP) and P2 phytosomes (P2P) were prepared by a thin-film rehydration method ( Figure 3A) . Blank lipid nanoparticles (P) were also prepared with the same process without drug. The particle sizes and zeta potentials of phytosomes were detected by dynamic light scattering (DLS). The characteristics of phytosomes were summarized in Table 2 . P2P showed the minimum size with an average diameter of about 53.6 ± 0.3 nm and DiP showed the slightly larger size with an average diameter of about 66.3 ± 0.3 nm (Figure 3B ). Nevertheless, P showed the maximum size with an average diameter of about 139.8 ± 1.1 nm, almost twice the size of DiP and P2P. The results showed that the addition of Di and P2 could decrease the particle size of lipid nanoparticles. The particle size of 100 nm diameter or less will be more beneficial to the blood circulation and tumor accumulation [33] .
Numerous studies have shown that cholesterol is crucial for structural stability of liposomal membranes [34] . The existence of cholesterol analogs Di and P2 in phytosomes could improve the structural stability of phytosomes. The zeta potentials of DiP and P2P were −6.4 and −4.0 mV, respectively. Because the negatively charged particles have weak interactions with negatively charged cell membrane, the anion nanoparticles could have less cytotoxicity than the cationic ones [35] . In addition, it was reported that the anion nanoparticles could be inclined to interact with the lung surfactant to make it more easily accessible into lung cells [36] . Therefore the phytosomes we prepared with size less than 100 nm and negative charges, will be more beneficial to lung cancer treatment.
The morphologies of the DiP and P2P were observed by transmission electron microscopy (TEM) and atomic force microscopy (AFM) (Figure 3C and 3D ). P2P and DiP demonstrated roughly homogeneous oval shape under TEM observation but showed spherical morphologies in the figures of AFM. According to the literature, a phytosome will display a micellar shape in aqueous solution [37] . The oval shape of P2P and DiP could be due to the aggregation of phytosomes during the sample preparation for TEM.
Anti-proliferative activity of P2P
To determine the cytotoxicity of DiP and P2P in lung cancer cells, cells were treated with different concentrations of P, DiP and P2P for different incubation times. The toxicity of the blank lipid nanoparticles was first investigated. As shown in Figure 4 , P did not show any anti-proliferative effects on A549 and PC9 cells, indicating the safety of the carrier materials. DiP and P2P showed efficient anti-proliferative activity in a dose-and time-dependent manner. DiP and P2P showed no obvious cytotoxicity after 24 h incubation. However, the anti-proliferative effects were greatly improved when the incubation time was extended to 72 h. The results indicated that the entrapped Di and P2 could be sustainedly released from phytosomes to exert effects.
As the drugs delivered to the lungs will be quickly eliminated due to large alveolar surface area, abundant capillaries and minimal transport distance, the sustained drug release delivery systems will improve the drug absorption and increase the activities [38] . Compared with DiP, P2P still showed better anti-proliferative effects against A549 and PC9 cells. As comparison, the IC50 values of Di and P2 against A549 and PC9 cells after 72 h were also calculated ( Table 1) . The IC50 values of Di and P2 against A549 and PC9 at 72 h were lower than the IC50 values at 48 h. Compared with free drugs, DiP and P2P showed comparable or better anti-proliferative effects after a 72 h-incubation. The results indicated that phytosomes could be an ideal drug delivery system for Di and its derivatives to gain sustained-release behavior without affecting drug activity.
In vitro anti-cancer mechanisms of P2P
Cell cycle and cell apoptosis were also investigated in A549 and PC9 cells to The cell apoptosis induced by P2P was significantly higher than that induced by DiP, indicating that P2 loaded in phytosomes could retain its anti-cancer activities. As shown in Figure 2C , A549 cells treated with P2 after 48 h were almost in the early phase of apoptosis. However, A549 cells treated with P2P after 72 h were almost in the late phase of apoptosis, suggesting that the actions of P2 on induction of cell apoptosis could be altered after loading in phytosomes. One reason might be the changed drug uptake pathway. The free drugs were uptaken by passive transport, while the phytosomes were uptaken through endocytosis [39] . Besides, the phytosomes containing abundant phospholipids could carry amphiphilic agents to cross the cell-membrane barrier to result in high intracellular drug concentration, which might change the action mechanisms of P2.
Conclusions
In conclusion, Di derivatives were designed and P2 was screened. P2 showed enhanced in vitro cytotoxic activities than that of Di against human non-small-cell lung cancer A549 and PC9 cells. To further improve the water solubility of Di and P2, DiP and P2P were prepared with a thin-film rehydration method. DiP and P2P exhibited particle sizes less than 100 nm with oval shape and negative charges.
Compared with free drugs, DiP and P2P showed comparable or better antiproliferative effects after a 72 h-incubation, and P2P still showed better antiproliferative effects through inducing apoptosis and cell cycle arrest against lung cancer cells compared with DiP. All the results indicated that P2P could be a promising anticancer formulation for lung cancer. 
Synthesis and characterization of FZU-0021-194-P2
To a solution of Di (829 mg, 2 mmol) in EtOH (25 mL) was added FePc (28 mg, 0.05 mmol), NaBH4 (378 mg, 10 mmol) and KCNO (811 mg, 10 mmol). The reaction mixture was stirred at r.t. under air for 48 h. The solvent was then evaporated to dryness and the residue was diluted with EtOAc (20 mL) and extracted with H2O (20 mL). The combined organic layers were washed with saturated brine, dried over anhydrous Na2SO4, filtered, which was purified by silica gel chromatography 
Preparation of phytosomes
DiP and P2P were prepared with lecithin in the prescribed ratio (1:1, molar ratio) by the thin film hydration method. First, lecithin and Di/P2 were dissolved in chloroform at a molar ratio of 1:1. The organic solvent was evaporated using a rotary evaporator to produce a thin lipid film. Before hydration, the lipid film was dried in a vacuum drying chamber at 27 o C for 12 h. The hydrated multilamellar vesicles were sonicated by a sonicator for 20 min. Blank lipid nanoparticles (P) were also prepared with the same process without adding Di or P2.
Characterization of phytosomes
The hydrodynamic diameters and zeta potentials of phytosomes were analyzed by DLS on a Malvern Instruments Zetasizer HS III (Malvern, UK) at room temperature.
The morphologies of the phytosomes were detected by atomic force microscopy (AFM, Multimode 8, Bruker, USA) and transmission electron microscopy (TEM, HT7700, Hitachi, Japan).
Cell cultures
The A549 and PC9 cells were obtained from the Cell Resource Center of Shanghai
Institute for Biological Sciences (Chinese Academy of Sciences, Shanghai, China).
The A549 and PC9 cells were grown in normal RPMI medium containing 10% FBS.
The cells were maintained in a moist cell incubator at 37 °C with 5% CO2.
In vitro cell viability
Cell viability was determined by MTT assay. Cells seeded in 96-well plates at 70-80% confluence were exposed to free drugs (Di, P2) and phytosomes (P, DiP, P2P) at various concentrations for 48 and 72 h. At the end of the treatment period, viability was determined by the MTT assay [40] .
Cell cycle analysis
A549 and PC9 cells were plated in six-well plates at 2×10 5 cells/well, respectively. analyzed by FACS Calibur system and the data was processed and analyzed using the ModFit software (Verity Software House, Topsham, ME) [41] .
Cell apoptosis
For analysis of apoptosis, A549 and PC-9 cells were cultivated with Di or P2 for 48 h and DiP or P2P for 72 h under normoxic condition. Then, cells were harvested, washed with PBS, and collected by centrifugation. The cell suspensions were mixed with 5 μL of FITC-Annexin V, 5 μL of PI, and 500 μL of binding buffer and kept for 15 min in the dark. Subsequently, the apoptotic stages were quantitatively determined by flow cytometry [42] .
Statistical analysis
All data shown in this article were expressed as the mean ± SD for at least three separate experiments. Statistical analysis was performed using the Student's t-test. 
